热门资讯> 正文
Citius Pharmaceuticals重新获得纳斯达克合规
2025-07-08 20:48
- Citius Pharmaceuticals (NASDAQ:CTXR) announced on Tuesday it received a Nasdaq notification, indicating that the company regained compliance with Nasdaq's minimum bid price requirement rule of $1.00 per share for continued listing.
- The company said the previously scheduled Nasdaq Hearing Panel has been cancelled. Nasdaq informed the company that Citius Pharma's securities will continue to be listed and traded on Nasdaq.
- CTXR +1.46% premarket to $2.1358.
- Source: Press Release
More on Citius Pharmaceuticals
- Citius Pharmaceuticals slides on $15.8M securities offering
- Citius Oncology enters distribution services agreement with Cardinal Health
- Seeking Alpha’s Quant Rating on Citius Pharmaceuticals
- Historical earnings data for Citius Pharmaceuticals
- Financial information for Citius Pharmaceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
